IP Library Granted Patent US 9,725,344
Granted Patent B1
US 9,725,344 · App. 15/501,478 · Granted Aug 8, 2017

Spiral wound filtration assembly including integral bioreactor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,725,344
App. No.
15/501,478
Granted
Aug 8, 2017
Kind
B1
Abstract

A spiral wound filtration assembly including: i) a pressure vessel comprising a feed port, concentrate port and permeate port; ii) at least one spiral wound membrane module comprising at least one membrane envelop wound around a permeate tube which forms a permeate pathway to the permeate port; and iii) a bioreactor having a cylindrical outer periphery extending along an axis (Y) from a first end to a second end, an inlet located near the first end, and an outlet located near the second end; wherein the spiral wound membrane module and bioreactor are serially arranged within the pressure vessel.

Claims (11)

1. A spiral wound filtration assembly comprising:

i) a pressure vessel ( 52 ) comprising a feed port ( 54 ), concentrate port ( 56 ) and permeate port ( 58 );

ii) at least one spiral wound membrane module ( 2 ) comprising at least one membrane envelop ( 4 ) wound around a permeate tube ( 8 ) which forms a permeate pathway to the permeate port ( 58 ); and

iii) a bioreactor ( 38 ) having a cylindrical outer periphery extending along an axis (Y) from a first end ( 76 ) to a second end ( 76 ′), an inlet ( 46 ) located near the first end ( 76 ), and an outlet ( 48 ) located near the second end ( 76 ′) and comprises at least one of:

1) a bed of particulates having bio-growth surfaces and flow channels between individual particles, wherein the bio-growth surfaces are defined as those surfaces adjacent to the flow channels that connect the inlet ( 46 ) and outlet ( 48 ) of the bioreactor ( 38 ) and wherein the flow channels have a void volume between bio-growth surfaces that is not occupied by a solid, and wherein the void volume of the flow channels is at least 65% of the volume of the bioreactor ( 38 ), and

2) a permeable flat sheet ( 40 ) having two opposing bio-growth surfaces ( 50 , 50 ′) and a feed spacer ( 42 ) defining flow channels ( 43 ) extending along the bio-growth surfaces ( 50 , 50 ′) of the flat sheet ( 40 ) from the inlet ( 46 ) to the outlet ( 48 ) of the bioreactor ( 38 ); wherein the flat sheet ( 40 ) is spirally wound about a solid rod or hollow conduit ( 44 ) sealed from fluid communication with the flat sheet ( 40 ) and feed spacer ( 42 ) and serially connected to the permeate tube ( 8 ) of the spiral wound membrane module ( 2 ) and; wherein the spiral wound membrane module ( 2 ) and bioreactor ( 38 ) are serially arranged within the pressure vessel ( 52 ).

2. The assembly of claim 1 wherein the flat sheet ( 40 ) is permeable and the two opposing bio-growth surfaces ( 50 , 50 ′) are in fluid communication with each other.

3. The assembly of claim 1 further comprising a plurality of spiral wound membrane modules ( 2 , 2 ′, 2 ″, 2 ″′), each comprising at least one membrane envelop wound ( 4 ) around a permeate tube ( 8 ), and wherein the spiral wound membrane modules ( 2 , 2 ′, 2 ″, 2 ″′) are serially arranged within the pressure vessel ( 52 ) with a first element ( 2 ) of the series positioned nearest to a first end ( 60 ) of the pressure vessel ( 52 ) and a last element ( 2 ″′) of the series positioned adjacent to an opposing second end ( 62 ) of the pressure vessel ( 52 ), and wherein the permeate tubes ( 8 ) of the spiral wound elements are serially connected to form a permeate pathway which is connected to the permeate port ( 58 ), and wherein the bioreactor ( 38 ) is arranged within said series at a location upstream of at least one spiral wound membrane module ( 2 ).

4. The assembly of claim 3 wherein the bioreactor ( 38 ) is arranged within the series at a location upstream of all spiral wound membrane modules ( 2 , 2 ′, 2 ″, 2 ″′).

5. The assembly of claim 1 wherein the feed spacer ( 42 ) of the bioreactor ( 38 ) provides flow channels ( 43 ) of from 0.10 mm to 1.5 mm between adjacent bio-growth surfaces ( 50 , 50 ′) of the flat sheet ( 40 ).

6. The assembly of claim 1 wherein the flow channels have a void volume between bio-growth surfaces that is not occupied by a solid, and wherein the void volume of the flow channels is at least 65% of the volume of the bioreactor.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2024
From: DOW GLOBAL TECHNOLOGIES LLC
To: THE DOW CHEMICAL COMPANY
Reel/Frame 069923/0030 →
CHANGE OF LEGAL ENTITY Recorded Sep 10, 2024
From: DDP SPECIALTY ELECTRONIC MATERIALS US, INC
To: DDP SPECIALTY ELECTRONIC MATERIALS US, LLC
Reel/Frame 068907/0881 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2024
From: THE DOW CHEMICAL COMPANY
To: DDP SPECIALTY ELECTRONIC MATERIALS US, INC
Reel/Frame 068922/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2017
From: JOHNSON, JON E
To: FILMTEC CORPORATION
Reel/Frame 042772/0655 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2017
From: FILMTEC CORPORATION
To: DOW GLOBAL TECHNOLOGIES LLC
Reel/Frame 042772/0740 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2017
From: JONS, STEVEN D
To: DOW GLOBAL TECHNOLOGIES LLC
Reel/Frame 042772/0862 →